AstraZeneca
oncology launch reinforces breast cancer leadership metastatic breast cancer poised to redefine potential soc for altered strong us launch momentum filings underway in | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
February 2024
Slide
17 of 45
Related slides by other companies
RenovoRx
IPO
August 2021
broad market opportunity in target cancers | RenovoRx
Exscientia
Results
March 2024
elucidate phase ongoing in advanced solid | Exscientia
Exscientia
Investor Day
January 2024
enabling studies complete | Exscientia
Immix Biopharma
Investor Presentation
January 2024
market opportunity oncology | Immix Biopharma
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io